- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
Thyrogen is a synthetic form of the human hormone thyrotropin alfa, used to treat thyroid cancer. It is used to stimulate the release of thyroid hormones from the thyroid gland, allowing for the detection of residual thyroid cancer cells. It is also used to reduce the risk of recurrence of thyroid cancer after surgery.
Thyrogen is a relatively new drug, having been approved by the US Food and Drug Administration in 1998. It is used in combination with radioactive iodine therapy, and is the only FDA-approved drug for this purpose. It is available in both injectable and oral forms.
The Thyrogen market is a growing one, with increasing demand for the drug due to its effectiveness in treating thyroid cancer. It is also becoming more widely available, with many countries now offering it as a treatment option.
Companies in the Thyrogen market include Genzyme Corporation, Merck & Co., Inc., and GlaxoSmithKline plc. Show Less Read more